These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 15661874)
1. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874 [TBL] [Abstract][Full Text] [Related]
2. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550 [TBL] [Abstract][Full Text] [Related]
3. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425 [TBL] [Abstract][Full Text] [Related]
4. Lysosomal cysteine proteases and antigen presentation. Rudensky A; Beers C Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. Honey K; Nakagawa T; Peters C; Rudensky A J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314 [TBL] [Abstract][Full Text] [Related]
6. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226 [TBL] [Abstract][Full Text] [Related]
8. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235 [TBL] [Abstract][Full Text] [Related]
9. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383 [TBL] [Abstract][Full Text] [Related]
10. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Nakagawa TY; Rudensky AY Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942 [TBL] [Abstract][Full Text] [Related]
11. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells. Costantino CM; Ploegh HL; Hafler DA J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543 [TBL] [Abstract][Full Text] [Related]
12. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813 [TBL] [Abstract][Full Text] [Related]
13. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692 [TBL] [Abstract][Full Text] [Related]
14. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M. Honey K; Forbush K; Jensen PE; Rudensky AY J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026 [TBL] [Abstract][Full Text] [Related]
15. Proteases, processing, and thymic selection. Cresswell P Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085 [No Abstract] [Full Text] [Related]
16. Cathepsin S activity regulates antigen presentation and immunity. Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206 [TBL] [Abstract][Full Text] [Related]
17. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073 [TBL] [Abstract][Full Text] [Related]
19. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331 [TBL] [Abstract][Full Text] [Related]
20. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Haque A; Hajiaghamohseni LM; Li P; Toomy K; Blum JS Cell Immunol; 2007 Sep; 249(1):20-9. PubMed ID: 18067883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]